The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Global Operations Update

27 Jun 2014 07:30

RNS Number : 6981K
Phorm Corporation Limited
27 June 2014
 

27 June 2014

 

Phorm Corporation Limited

("Phorm" or the "Company")

 

Global Operations Update

Revenue and KPIs Growing Strongly

Phorm (AIM: PHRM), a leading internet personalisation technology company, announces an unaudited operational and financial update demonstrating that the group's revenues and key performance indicators (KPIs) are continuing to grow strongly.

Highlights:

· Peak daily unique user numbers have increased 44 times from approximately 838,000 in H1 2013 to in excess of 30 million in H1 2014

· Advertising requests have increased 35 times from approximately 1.6 billion in H1 2013 to approximately 60 billion in H1 2014

· Advertising impressions served have increased 35 times from approximately 63 million in H1 2013 to over 2.3 billion in H1 2014

· Revenue has grown by more than 14 times year-on-year, H1 2013 versus H1 2014*

· Monthly revenue from January to May 2014 has grown by over 300%

· Revenue growth is expected to accelerate significantly in H2 2014, following the recent growth in user numbers and advertising requests

 

On 24 October 2013, Phorm announced that it had experienced strong growth in its KPIs and on 27 January 2014 further announced that it had launched commercial operations in China. The Company is pleased to announce that the group's strong growth trend in revenue and other KPIs is continuing.

 

Key Performance Indicator

H1 2013

H2 2013

H1 2014*

Yr-on-Yr

Peak Daily Unique Users (m)

0.8

14.1

37.8

44x

Total Advertising Requests (bn)

1.6

22.3

59.9

35x

Total Advertisements Served (m)

63.0

777.8

2,328.6

35x

Total Revenues (US$'000s)

28.5

251.2

>400.0

14x

Note:

* Total revenues for H1 2014 are for the five-month period to 31 May 2014 i.e. excluding June 2014. Users, Advertising Requests and Advertisements Served are for the period from 1 January 2014 to 19 June 2014

 

As outlined in the Company's 2013 Annual Report published today, there are four main drivers of Phorm's business, being: users, publishers, advertisers and advertisement performance. All of these key elements need to be developed and progressed in each target market before significant revenues can be generated.

 

On 27 March 2014, the Company announced that it had reached a total of over 30 million daily unique users globally. The peak daily unique user number in H1 2013 has increased approximately 44 times year-on-year in H1 2014. The growth in user numbers has been driven primarily by the development of new markets and is currently expected to translate into higher revenues over the coming months, as both inventory and advertising campaigns increase.

 

Inventory refers to the number of advertising slots on web pages that are made available to Phorm's system. Inventory is presented as an advertising request from the publisher site as a web page loads on a user's browser. The number of advertising requests received demonstrates the strength of Phorm's publisher partnerships. The number of partnerships has increased and advertising requests have grown significantly, increasing 35 times year-on-year from approximately 1.6 billion in H1 2013 to approximately 60 billion in H1 2014.

 

The main challenge that the Company has faced in recent years has been the relatively small number of users, which has had a major impact on the group's ability to monetise the advertising requests sent from publishers. Of the approximate 1.6 billion advertising requests received in H1 2013, only 129 million, or 8 per cent., related to users who had consented to Phorm's system. In H1 2014, the total number of requests had risen to approximately 60 billion and over 27 billion of these, or 45 per cent., were from Phorm users.

 

The growth in the number of advertising requests attributable to Phorm users has greatly improved the Company's ability to deliver larger advertising campaigns more rapidly, thereby enhancing the rate of revenue generation.

 

The total number of advertising impressions actually served has increased approximately 35 times from 63 million in H1 2013 to over 2.3 billion in H1 2014. Phorm currently expects this growth to strengthen over the remainder of 2014 with the gathering momentum and further commercialisation of its operations in China.

 

On 30 September 2013, Phorm announced that its total revenue for the six months ended 30 June 2013 was US$28,545. The Company is pleased to announce that its unaudited total revenue for the period from 1 January 2014 to the end of May 2014 is over US$400,000 representing an increase of over 14 times on H1 2013. Based on the lead KPIs of user numbers, advertising requests and advertising impressions, the Company currently expects this growth to continue to strengthen through the remainder of 2014.

 

The Company is focused on accelerating the rate of revenue growth while maintaining the high standards of advertising performance achieved to date and will provide further updates in due course.

 

-Ends-

 

For further information please contact:

 

Phorm Corporation Limited

Andy Croxson (analysts and investors) +44 (0) 203 397 6001

 

UK Investors

Mirabaud Securities LLP +44 20 7321 2508 (Broker)

Jason Woollard

Peter Krens

 

Strand Hanson Limited +44 20 7409 3494 (Nominated Adviser)

James Harris

Matthew Chandler

James Dance

 

US Investors

Lippert/Heilshorn and Associates +1 212 838 3777 (Investor Relations)

John Heilshorn

 

 

 

 

About Phorm

 

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

 

Phorm's industry leading technology enables its Internet Service Provider ("ISP") partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalised content for opted-in users.

 

Phorm's advertising platform revolutionises current standards of online privacy, fully protecting the identity of consumers. Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.

 

Phorm's partners include leading ISPs, Publishers, Advertising Networks and Advertisers.

 

Phorm, under a predecessor holding company, was admitted to the AIM market of the London Stock Exchange in 2004.

 

For more information, please visit: www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNVURSSANUUR
Date   Source Headline
26th Mar 20145:00 pmRNSIntention to raise £10 million
10th Mar 20147:01 amRNSMemorandum of Understanding with China Telecom
27th Jan 20147:00 amRNSCommercial Launch in China
20th Jan 20147:00 amRNSChange of Adviser
17th Jan 20147:00 amRNSAIM Rule 17 Disclosure Schedule Two (g) Update
6th Jan 20147:00 amRNSExercise of Employee Warrants for Shares
19th Nov 20137:00 amRNSOperational Update for Phorm China
19th Nov 20137:00 amRNSEquity Placing to raise £10 million
13th Nov 20137:12 amRNSStmnt re Share Price Movement
24th Oct 201311:16 amRNSOperations Update
3rd Oct 20137:00 amRNSOperational Launch in China
30th Sep 20137:00 amRNSInterim Results
27th Sep 20137:00 amRNSOperations Update
28th Aug 201312:43 pmRNSAGM Statement
7th Aug 201310:52 amRNSStmnt re Share Price Movement
6th Aug 20137:00 amRNSAGM Statement
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
17th Jul 20139:20 amRNSIssue of Equity
28th Jun 20137:20 amRNSAnnual Report and Financial Statements
28th Jun 20137:20 amRNSTurkish Operations Update
29th May 20137:00 amRNSFinancing Update
8th May 20138:34 amRNSHolding(s) in Company
23rd Apr 201310:18 amRNSPlacing to raise £7.15 million
21st Mar 20133:20 pmRNSStatement re Share Price Movement
20th Mar 20137:00 amRNSFinancing Update
24th Jan 20137:00 amRNSChinese and Turkish Operations Update
4th Jan 20137:00 amRNSIssue of Shares
18th Dec 20127:00 amRNSIssue of Shares
17th Dec 20127:00 amRNSTurkish Operational Update
13th Dec 20127:00 amRNSTR1: Notification of major interest in shares
21st Nov 201212:33 pmRNSResult of EGM & Admission to trading
6th Nov 201211:50 amRNS£6m Placing, Contract Signature & Turkey Update
16th Oct 20127:00 amRNSCommercial Progress Update
28th Sep 20127:00 amRNSInterim Results
20th Sep 20127:00 amRNSUpdate on Turkey and Phorm China Equity Fundraise
11th Sep 20127:00 amRNSAdmission to Trading
10th Sep 20123:33 pmRNSSch 1 Update - Phorm Corporation Limited
7th Sep 20122:58 pmRNSResults of EGM - Correction
7th Sep 201212:29 pmRNSResults of EGM
5th Sep 20124:15 pmRNSNotification of Major Interests in Shares
31st Aug 20123:49 pmRNSUpdated Appendix to Schedule 1
13th Aug 20129:06 amRNSSchedule 1 - Phorm Corporation Limited
13th Aug 20127:00 amRNSPhorm Re-Domicile of Holding Company from Delaware
2nd Aug 20127:00 amRNSPlacing
9th Jul 20127:00 amRNSCommencement of Commercial Activities with TTNET
3rd Jul 201210:14 amRNSTransfer of Shares
29th Jun 20127:00 amRNSAnnual Financial Report
19th Jun 20126:01 pmRNSCorrection: AGM Result
19th Jun 201211:29 amRNSAGM Result

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.